Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-03-15 | New | $1,516,746 | $1,516,746 | Debt Only | 04 06b | SEC link |
| 2023-02-14 | New | $3,452,576 | $3,452,576 | Equity Only | 04 06b | SEC link |
| 2015-01-21 | New | $2,487,487 | $2,487,487 | Equity Only | 06b 4a5 | SEC link |
| 2011-06-28 | New | $100,123 | $100,123 | Equity Only | 06 46 | SEC link |
| 2010-05-12 | New | $550,000 | $550,000 | Equity Only | 06 46 | SEC link |
| Name | Role |
|---|---|
| Lu Alleruzzo | Executive |
| Luciano Alleruzzo | Director, Executive, Promoter |
| Shelly L. Bishop | Director |
| Charlie Bolten | Director |
| Wei R. Chen | Director, Promoter |
| Tomas Hode | Director, Executive, Promoter |
| Peter A. Jenkins | Director |
| Jonathan Knowles | Director |
| Robert E. Nordquist | Director |
| Bobby W. Sandage | Director |
| David Smoller | Director |
| Miguel Zubizarreta | Director |